Petros Pharmaceuticals, Inc. (PTPI) NASDAQ
0.01
-0.0011(-18.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.25M |
| Enterprise Value | -5.13B |
| P/E Ratio | 0.07 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | 0.73 |
| Return On Equity | 0 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -4.64M |
| Net Income | 1.91M |
| Diluted EPS | -1.56 |
Balance Sheet
| Total Cash | 4.35M |
| Total Cash/Share | 0.09 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.68 |
| Book Value Per Share | 0.04 |
Price History
| 52-Week Change | -85.71 |
| 52-Week High | 0.04 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.01 |
Statistics
| Average Volume | 106,587 |
| Shares Outstanding | 31.16M |
| % Held by Institutions | 3.35 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.07 |
| Last Split Factor | 1:25 |
| Last Split Date | May 01, 2025 |
